Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wieslawa H Dragowska

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Molecular Cancer Therapeutics|July 29, 2003
Inhibition of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase enhances chemotherapeutic effects on H460 human non-small cell lung cancer cells through activation of apoptosisYanping Hu, Marcel Bally, Wieslawa H Dragowska, et al.
Vaccine|June 14, 2003
Effective induction of CD8+ T-cell response using CpG oligodeoxynucleotides and HER-2/neu-derived peptide co-encapsulated in liposomesWai Ming Li, Wieslawa H Dragowska, Marcel B Bally, et al.
Drug Delivery and Translational Research|April 23, 2017
In vitro assay for measuring real time topotecan release from liposomes: release kinetics and cellular internalizationRoger Gilabert-Oriol, Lina Chernov, Malathi Anantha, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 18, 2018
Copper-CX-5461: A novel liposomal formulation for a small molecule rRNA synthesis inhibitorAda W Y Leung, Malathi Anantha, Wieslawa H Dragowska, et al.
Current Drug Delivery|November 25, 2005
The formulation of lipid-based nanotechnologies for the delivery of fixed dose anticancer drug combinationsEuan C Ramsay, Nancy Dos Santos, Wieslawa H Dragowska, et al.
Cancer Biology & Therapy|January 17, 2004
Pharmacodynamic behavior of liposomal antisense oligonucleotides targeting Her-2/neu and vascular endothelial growth factor in an ascitic MDA435/LCC6 human breast cancer modelDawn N Waterhouse, Wieslawa H Dragowska, Karen A Gelmon, et al.
Oncogene|March 23, 2005
Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growthLincoln A Edwards, B Thiessen, Wieslawa H Dragowska, et al.
Investigational New Drugs|July 23, 2017
Copper (II) complexes of bidentate ligands exhibit potent anti-cancer activity regardless of platinum sensitivity statusMohamed Wehbe, Cody Lo, Ada W Y Leung, et al.
Cancer Research|November 13, 2003
Aberrant expression of T-plastin in Sezary cellsMing-wan Su, Irene Dorocicz, Wieslawa H Dragowska, et al.
Drug Delivery and Translational Research|December 17, 2017
Development of a copper-clioquinol formulation suitable for intravenous useMoe Wehbe, Armaan K Malhotra, Malathi Anantha, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Molecular Cancer Therapeutics|July 29, 2003
Inhibition of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase enhances chemotherapeutic effects on H460 human non-small cell lung cancer cells through activation of apoptosisYanping Hu, Marcel Bally, Wieslawa H Dragowska, et al.
Vaccine|June 14, 2003
Effective induction of CD8+ T-cell response using CpG oligodeoxynucleotides and HER-2/neu-derived peptide co-encapsulated in liposomesWai Ming Li, Wieslawa H Dragowska, Marcel B Bally, et al.
Drug Delivery and Translational Research|April 23, 2017
In vitro assay for measuring real time topotecan release from liposomes: release kinetics and cellular internalizationRoger Gilabert-Oriol, Lina Chernov, Malathi Anantha, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 18, 2018
Copper-CX-5461: A novel liposomal formulation for a small molecule rRNA synthesis inhibitorAda W Y Leung, Malathi Anantha, Wieslawa H Dragowska, et al.
Current Drug Delivery|November 25, 2005
The formulation of lipid-based nanotechnologies for the delivery of fixed dose anticancer drug combinationsEuan C Ramsay, Nancy Dos Santos, Wieslawa H Dragowska, et al.
Cancer Biology & Therapy|January 17, 2004
Pharmacodynamic behavior of liposomal antisense oligonucleotides targeting Her-2/neu and vascular endothelial growth factor in an ascitic MDA435/LCC6 human breast cancer modelDawn N Waterhouse, Wieslawa H Dragowska, Karen A Gelmon, et al.
Oncogene|March 23, 2005
Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growthLincoln A Edwards, B Thiessen, Wieslawa H Dragowska, et al.
Investigational New Drugs|July 23, 2017
Copper (II) complexes of bidentate ligands exhibit potent anti-cancer activity regardless of platinum sensitivity statusMohamed Wehbe, Cody Lo, Ada W Y Leung, et al.
Cancer Research|November 13, 2003
Aberrant expression of T-plastin in Sezary cellsMing-wan Su, Irene Dorocicz, Wieslawa H Dragowska, et al.
Drug Delivery and Translational Research|December 17, 2017
Development of a copper-clioquinol formulation suitable for intravenous useMoe Wehbe, Armaan K Malhotra, Malathi Anantha, et al.
Pageof 3